Vanda Pharmaceuticals Inc. 4
4 · Vanda Pharmaceuticals Inc. · Filed Dec 13, 2006
Insider Transaction Report
Form 4
Ramsay David Russ
Director
Transactions
- Sale
Common Stock
2006-12-11$26.40/sh−20,950$553,080→ 148,776 total(indirect: See Footnote) - Sale
Common Stock
2006-12-11$26.40/sh−305,375$8,061,900→ 2,169,104 total(indirect: See Footnote)
Footnotes (2)
- [F1]The reportable securities are owned directly by Care Capital Investments II, L.P. and indirectly by Care Capital II, LLC as general partner of Care Capital Investments II, L.P. The reporting person is a managing member of Care Capital II, LLC. The reporting person disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
- [F2]The reportable securities are owned directly by Care Capital Offshore Investments II, L.P. and indirectly by Care Capital II, LLC as general partner of Care Capital Offshore Investments II, L.P. The reporting person is a managing member of Care Capital II, LLC. The reporting person disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.